Dengvaxia
Dengue tetravalent vaccine, live.
The US FDA has approved Dengvaxia only for children aged 9-16 years. It may increase the likelihood of contracting serious infection in other age groups.
Citation
Venes, Donald, editor. "Dengvaxia." Taber's Medical Dictionary, 24th ed., F.A. Davis Company, 2021. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/774433/all/Dengvaxia.
Dengvaxia. In: Venes DD, ed. Taber's Medical Dictionary. F.A. Davis Company; 2021. https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/774433/all/Dengvaxia. Accessed November 17, 2024.
Dengvaxia. (2021). In Venes, D. (Ed.), Taber's Medical Dictionary (24th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/774433/all/Dengvaxia
Dengvaxia [Internet]. In: Venes DD, editors. Taber's Medical Dictionary. F.A. Davis Company; 2021. [cited 2024 November 17]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/774433/all/Dengvaxia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dengvaxia
ID - 774433
ED - Venes,Donald,
BT - Taber's Medical Dictionary
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/774433/all/Dengvaxia
PB - F.A. Davis Company
ET - 24
DB - Nursing Central
DP - Unbound Medicine
ER -